Meng Jiao
发表
miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4
B. Han,
Hui Liu,
Xuesen Dong,
2020,
The Prostate.
Zhan-tao Xie,
Y. Chu,
Ronghua Liu,
2021,
Immunotherapy advances.
B. Han,
P. Su,
T. Feng,
2019,
Oncogenesis.
B. Han,
Hui Liu,
T. Feng,
2018,
Neoplasia.
B. Han,
M. Qi,
Jing Zhang,
2019,
The Prostate.
W. Teng,
Facai Zhang,
Chengjun Zhou,
2022,
International journal of general medicine.
Mingwen Jiao,
Hui Yang,
Z. Cui,
2020
.
B. Han,
Hui Liu,
Zhiyan Liu,
2019,
The Prostate.
B. Han,
Hui Liu,
Feifei Sun,
2019,
Anti-cancer drugs.
Xiaorong Yang,
Feifei Sun,
Hongwei Guo,
2023,
Molecular and cellular probes.
B. Han,
Hui Liu,
Geng-yin Zhou,
2018,
Translational oncology.
Hui Liu,
Jing Zhang,
B. Han,
2019
.
miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4
Bo Han,
Hui Liu,
Jing Zhang,
2020,
The Prostate.
L. Wang,
Y. Gong,
L. Liu,
2018,
Oncogene.
Jiaping Ni,
Ying Li,
Haoying Zhang,
2021,
Pharmacological research.
M. Qi,
Jing Zhang,
Jing Hu,
2019
.